Table 3.
Indirect effects of expectancy and decline in blood bicarbonate on TTE
| Pathway | b (SE) | 95% CI | PSIE (SE) | 95% CI |
|---|---|---|---|---|
| Indirect effects on TTE via expectancy | ||||
| D1 | − 10.95 (14.3) | − 40.50 to 16.58 | − 0.15 (0.20) | − 0.57 to 0.23 |
| D2 | − 13.00 (17.25) | − 49.83 to 17.65 | − 0.18 (0.24) | − 0.71 to 0.24 |
| D3 | − 11.63 (15.55) | − 45.35 to 16.16 | − 0.16 (0.22) | − 0.64 to 0.22 |
| D4 | − 2.05 (15.49) | − 18.16 to 5.67 | − 0.03 (0.08) | − 0.25 to 0.08 |
| D5 | − 0.68 (5.37) | − 14.48 to 8.34 | − 0.01 (0.08) | − 0.20 to 0.12 |
| D6 | 1.37 (4.96) | − 7.1 to 14.62 | 0.02 (0.07) | − 0.10 to 0.20 |
| Indirect effects on TTE via decline in blood bicarbonate | ||||
| D1 | − 9.45 (18.29) | − 46.51 to 26.73 | − 0.13 (0.25) | − 0.64 to 0.38 |
| D2 | − 38.33 (20.39) | − 81.49 to − 2.15 | − 0.53 (0.28) | − 1.12 to − 0.03 |
| D3 | − 37.93 (18.87) | − 76.18 to − 2.61 | − 0.53 (0.26) | − 1.04 to − 0.04 |
| D4 | − 28.88 (15.49) | − 63.25 to 1.75 | − 0.40 (0.21) | − 0.88 to 0.02 |
| D5 | − 28.48 (15.12) | − 61.49 to − 0.73 | − 0.39 (0.21) | − 0.84 to − 0.01 |
| D6 | 0.39 (12.29) | − 23.04 to 25.96 | 0.01 (0.17) | − 0.31 to 0.37 |
| Indirect effects on TTE via expectancy and decline in blood bicarbonate | ||||
| D1 | − 27.64 (15.08) | − 63.68 to − 5.63 | − 0.38 (0.20) | − 0.84 to − 0.09 |
| D2 | − 32.83 (16.10) | − 71.32 to − 8.33 | − 0.45 (0.20) | − 0.92 to − 0.13 |
| D3 | − 29.37 (15.05) | − 65.97 to − 6.75 | − 0.41 (0.19) | − 0.86 to − 0.10 |
| D4 | − 5.18 (8.47) | − 23.18 to 10.98 | −0.07 (0.11) | − 0.31 to 0.15 |
| D5 | − 1.73 (8.72) | − 19.48 to 16.59 | − 0.02 (0.12) | − 0.26 to 0.23 |
| D6 | 3.46 (8.12) | − 12.50 to 21.95 | 0.05 (0.11) | − 0.17 to 0.30 |
Unstandardised coefficients are shown
Bold indicates difference (p < 0.05)
SE standard error, PSIE partially standardized indirect effect, TTE time-to-exhaustion
D1 = SB-SOL versus SB-CAP, D2 = SB-SOL versus PL-SOL, D3 = SB-SOL versus PL-CAP, D4 = SB-CAP versus PL-SOL, D5 = SB-CAP versus PL-CAP, D6 = PL-SOL versus PL-CAP